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Objective: To define cumulative risk of reconstruction, amputation or death following percutaneous transluminal 
angioplasty (PTA). 
Design: Non-randomised observational study. 
Patients and Methods: Two hundred and thirty-four PTAs in 212 patients. Minimum follow-up 6 months. Examination 
of data collected prospectively on manual card index. Examination of radiology and theatre ledgers over 2.5-year period. 
District Information System (Dis Data). Life-table analysis. 
Results: The cumulative risks of reconstruction at 12 months were 14.9% and 6.7%, respectively, following angioplasties 
below and above the inguinal ligament. Major and minor amputations were more common if the original lesions were 
below the inguinal igament (relative risk (RR) 3.32, confidence interval (CI) CI 0.42-26.26 and RR 4.24, CI 0.055-32.9, 
respectively). They were also more likely in diabetic compared with non-diabetic patients (RR 9.95, CI 2.85-34.47 and 
RR 3.66, CI 1.28-10.44, respectively). No patient who presented with claudication underwent amputation. Death was 
more common in patients originally presenting with rest pain or gangrene than claudication (RR 3.94, CI 1.51-10.31). 
Conclusion; This study confirms the poor outlook of diabetic patients with peripheral vascular disease or those presenting 
with rest pain, ulceration or gangrene. Percutaneous transluminaI angioplasty was associated with approximately 80% 
limb salvage rate in those patients during the duration of the study. 
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Introduction Methods 
Increasing numbers of patients are undergoing per- 
cutaneous transluminal ngioplasty (PTA). ~'2 A recent 
study showed that in one unit PTA had become the 
first line of treatment in 42% of patients presenting 
with critical imb ischaemia. 3 Patency rates are widely 
reported after PTA, but this does not necessarily cor- 
relate with clinical results. 4 Functional results of an- 
gioplasty are of more relevance to the patient. The 
patient presenting with claudication wants to know 
whether his quality of life will be improved with 
the procedure, whilst the patient with critical limb 
ischaemia wants to know whether the limb will be 
salvaged. Of relevance to both groups will be the 
likelihood of surgical reconstruction being required 
following angioplasty. 
The aim of this paper is to define the cumulative 
risk of reconstruction, amputation or death following 
PTA. 
Please address all correspondence to: R. B. Galland. 
As part of a continuing audit, data on patients with 
arterial disease have been prospectively collected on 
a card index. Demographic data, type and duration 
of symptoms, investigation and management are all 
recorded. 
Details of all patients undergoing PTA over 2.5 
years (between I July 1989 and 31 December 1991) for 
peripheral arterial disease were obtained from ledgers 
of the radiology department at the Royal Berkshire 
Hospital. Operating theatre ledgers of all West Berk- 
shire hospitals (Royal Berkshire, Battle and BUPA 
Dunedin Hospital) undertaking peripheral arterial re- 
construction, major and minor amputation were also 
examined. 
To ensure that no patients undergoing PTA were 
missed, details of patients undergoing these pro- 
cedures were also sought from District Information 
Systems (DIS), using Office of Population Censuses 
and Surveys 4th Revision operation codes L48-68 and 
X09. Data from the manual card index and hospital 
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case notes were used to resolve missing and conflicting 
data. All procedures found in theatre and X-ray de- 
partment ledgers or card index were included. Pro- 
cedures found in DIS were only included if confirmed 
by a second search of the ledgers or by reference to 
card index or case notes. 
The card index, DIS and case notes were also used 
to determine patients' symptoms (intermittent clau- 
dication, rest pain, ulcer or gangrene), the type of 
lesion (stenosis or occlusion), site of PTA (above or 
below the inguinal ligament), and the presence of 
diabetes. Details of smoking status and claudication 
distance were not included in the study because the 
data were unsupported by objective measurements. 
Data from all sources were entered on to a com- 
puterised atabase (EpiInfo) and linked according to 
patient name, and site and side of procedure. Names 
of all patients undergoing PTA were then checked 
against he West Berkshire death certificate database 
(which contained returns from the Registrar of Deaths, 
including deaths of West Berkshire residents occurring 
outside the district) for 3 years from the start of the 
study. These patients had a minimum follow-up of 6 
months, or until death. 
In order to estimate the degree of cross-boundary 
flow and the possibility of patients having re- 
constructions or amputations outside Berkshire, Mer- 
sey Cross Boundary Flow Clearing House Data for the 
year from i April 1991 to 31 March 1992 were examined 
using the Office of Population Censuses and Surveys 
4th Revision operation codes as above (Clearing House 
data did not exist before 1 April 1991). 
Using life-table analysis we estimated cumulative 
survival and cumulative incidence of arterial re- 
construction and amputation following PTA. 5'6 
In constructing life tables, loss to follow-up was 
recorded at the last time the patient was seen during 
the study period. 
Results 
The degree to which patients might have been lost to 
follow-up due to subsequent treatment outside the 
district is not known precisely. However, Mersey Cross 
Boundary Flow Clearing House Data for the year from 
1 April 1991 to 31 March 1992 recorded only three 
bypasses, two PTAs and one major amputation i West 
Berkshire residents taking place outside the district. 
None involved patients included in this study. 
During the period of the study 234 PTAs were 
carried out on 212 patients. There were 136 men and 
76 women. The indication for angioplasty was rest 
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Fig. 1. Cumulative survival following angioplasty. Angioplasty 
above (A), below (11) inguinal ligament. 
pain or gangrene in 64 and intermittent claudication 
in the remainder. Forty-nine PTAs were carried out 
above the inguinal ligament and 185 below it. The 
mean age of patients having angioplasty above the 
inguinal igament was 62.8 years (39-83). Those having 
more distal procedures were aged 68.4 years (27-98). 
Seventy-seven occlusions were angioplastied (median 
length 5 cm, range 1-30 cm), the remainder being either 
single or multiple stenoses. Diabetes was present in 
45 patients. Patients with diabetes were more likely 
to have disease below the inguinal ligament (RR 3.2, 
95% CI 1.09-9.42). 
Figure 1 (Tables 1 and 2) shows the cumulative 
survival following angioplasty. There was no dif- 
ference in survival depending upon site of original 
lesion. Patients presenting with rest pain or gangrene 
had a significantly reduced survival compared with 
those patients presenting originally with claudication 
(Table 3). Similarly, survival in diabetic patients was 
worse, just failing to reach statistical significance. 
Surgical reconstruction was carried out in 27 
patients, 14 of whom presented with rest pain or 
gangrene. Three patients (6%) had had angioplasty 
above the inguinal igament. Operations were carried 
out at 1, 13 and 92 days postangioplasty. This compares 
with 24 patients (13%) who required reconstruction 
following angioplasty below the inguinal ligament. 
The cumulative incidence of reconstruction following 
angioplasty below the inguinal igament was 8.6% (s.E. 
2.4) at 6 months, 14.9% (s.E. 3.6) at 12 months and 
20.3% (s.•. 4.5) at 18 months (Fig. 2, Tables 4 and 5). 
One patient required amajor amputation 14 months 
after angioplasty above the inguinal igamer~t. By con- 
trast, 12 patients (6.5%) having originally had an- 
gioplasty below the inguinal igament required amajor 
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Table 1. Life table: cumulative survival following below inguinal ligament angioplasty. 
Time interval No. of Deaths No. lost to No. of Risk of 
after angioplasty angioplasties during follow-up angioplasties dying 
(days) entering time interval during at risk during 
interval interval interval 
Chance of Cumulative Standard 
surviving chance of error 
interval surviving 
without 
dying 
0-90 179 7 33 162.5 0.0431 0.956 0.956 0.0156 
91-180 146 1 15 138.5 0.0072 0.993 0.949 0.0177 
181-270 131 1 20 121 0.0083 0.992 0.942 0.0195 
271-360 111 1 22 100 0.0100 0.990 0.933 0.0218 
361-450 89 1 18 80 0.0125 0.988 0.921 0.0250 
451-540 71 2 11 65.5 0.0305 0.970 0.894 0.0323 
541-630 60 2 15 52.5 0.0381 0.962 0.860 0.0419 
631-720 45 0 10 40 0 1 - -  - -  
721-810 35 1 15 27.5 0.0364 0.964 0.829 0.0542 
811-900 20 1 12 14 0.0714 0.929 0.770 0.0844 
Table 2. Life table: cumulative survival following above inguinal ligament angioplasty. 
Time interval No. of Deaths No. lost to No. of Risk of 
after angioplasty angioplasties during follow-up angioplasties dying 
(days) entering time interval during at risk during 
interval interval interval 
Chance of Cumulative Standard 
surviving chance of error 
interval surviving 
without 
dying 
0-90 47 1 3 45.5 0.0220 0.978 0.978 0.0215 
91-180 43 0 6 40 0 1 0.978 - -  
181-270 37 1 8 33 0.0303 0.970 0.949 0.0355 
271-360 28 0 4 26 0 1 0.949 - -  
361-450 24 0 5 21.5 0 1 0.949 - -  
451-540 19 0 3 17.5 0 1 0.949 - -  
541-630 16 0 5 13.5 0 1 0.949 - -  
631-720 11 0 0 11 0 1 0.949 - -  
721-810 11 1 2 10 0.1000 0.900 0.854 0.0912 
811-900 8 2 3 6.5 0.3077 0.692 0.591 0.1432 
Table 3. Outcome following angioplasty (RR = Relative risk with 
95% CI). 
Outcome Comment 
Bypass (n =27) Original lesion below RR=2.29 (0.66-7.96) 
inguinal igament in 24 
Major Original lesion below RR = 3.32 (0.42-26.26) 
amputation (n = inguinal igament in 12 
13) 
All patients presented K2 36.6, dd. 1, p<0.001 
with ulceration or 
gangrene 
Eight patients were RR = 9.95 (2.85-34.47) 
diabetic 
Minor Original lesion below RR = 4.24 (0.55-32.9) 
amputation (n = inguinal igament in 15 
16) 
All patients had 1(2 45.6, d.f. 1, p<0.001 
ulceration or gangrene 
Seven patients were RR=3.66 (1.28-10.44) 
diabetic 
Death (n = 19) Eleven patients RR = 3.94 (1.51-10.31) 
presented with rest 
pain or gangrene 
Eight patients were RR = 2.49 (0.98-6.32) 
diabetic 
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Fig. 2. Cumulative risk of reconstruction following angioplasty. 
Angioplasty above (A), below (11) inguinal igament. 
amputat ion  (Fig. 3, Tab le  6). The  cumulat ive  inc idence  
of ma jor  amputat ion  fo l low ing  ang iop las ty  be low the  
ingu ina l  l igament  was  5.8% (s.E. 1.9) at  6 months ,  7.7% 
(s.E. 2.2) at  12 months  and  8.9% (s.E. 2.5%) at  18 
months .  A l l  pat ients  hav ing  major  amputat ion  or i -  
g ina l ly  p resented  w i th  e i ther  res t  pa in  or  gangrene  
ra ther  than  c laud icat ion  (p<0.001). S imi lar ly ,  minor  
amputat ions  were  on ly  requ i red  in  pat ients  present ing  
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Table 4. Life table: cumulative incidence of arterial reconstruction (at same site and on same side) fo l lowing be low inguinal l igament 
angioplasty. 
Time interval No. of RecOnstruc- No. lost to No. of Risk of Chance of Cumulative Standard 
after angioplasty angioplasties tions during follow-up angioplasties having surviving chance of error 
(days) entering time interval during at risk during reconstruction interval surviving 
interval interval interval without without 
(including having a having a 
amputations) reconstruction reconstruction 
0-90 179 8 37 160.5 0.0498 0.950 0.950 
91-180 138 5 15 130.5 0.0383 0.962 0.914 
181-270 118 5 20 108 0.0463 0.954 0.872 
271-360 93 2 20 83 0.0241 0.976 0.851 
361-450 72 4 17 63.5 0.0630 0.937 0.797 
451-540 53 - -  8 49 - -  1 0.797 
541-630 45 - -  10 40 - -  1 0.797 
631-720 35 - -  8 31 - -  1 0.797 
721-810 28 - -  11 22.5 - -  1 0.797 
811-900 17 - -  12 11 - -  1 0.797 
0.0167 
0.0236 
0.0307 
0.0355 
0.0451 
Table 5. Life table: cumulative incidence of arterial reconstruction (at same site and on same side) fo l lowing above inguinal l igament 
angioplasty. 
Time interval No. of Reconstruc- 
after angioplasty angioplasties tions during 
(days) entering time interval 
interval 
No. lost to No. of Risk of Chance of 
follow-up angioplasties having surviving 
during at risk during reconstruction interval 
interval interval without 
(including having a 
amputations) reconstruction 
Cumulative 
chance of 
surviving 
without 
having a 
reconstruction 
Standard 
error 
0-90 47 3 
91-180 41 - -  
181-270 35 - -  
271-360 26 - -  
361--450 22 - -  
451-540 17 - -  
541-630 14 - -  
631-720 9 - -  
721-810 9 - -  
811-900 7 - -  
4 45 0.0667 0.933 93.3 0.0359 
6 38 - -  1 93.3 - -  
9 30.5 - -  1 93.3 - -  
4 24 - -  1 93.3 - -  
5 19.5 - -  1 93.3 - -  
3 15.5 - -  1 93.3 - -  
5 11.5 - -  1 93.3 - -  
0 9 - -  1 93.3 - -  
2 8 - -  1 93.3 - -  
4 5 - -  1 93.3 - -  
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Fig. 3. Cumulative risk of major amputation following angioplasty 
below inguinal igament. 
w i th  res t  pa in  or  gangrene  (p<0.001). D iabet ic  pat ients  
were  s ign i f i cant ly  more  l i ke ly  to requ i re  major  or  
minor  amputat ion  compared  w i th  non-d iabet ic  
pat ients  (Table  2). 
Fo l low ing  d i la ta t ion  of s tenoses  19 pat ients  (12%) 
subsequent ly  requ i red  reconst ruct ion ,  10 (6.4%) a 
major  and  10 (6.4%) a minor  amputat ion .  These  resu l t s  
were  not  s ign i f i cant ly  d i f fe rent  f rom those  fo l low ing  
PTA for  occ lus ions .  E ight  of these  pat ients  (10.3%) 
requ i red  reconst ruct ion ,  th ree  (3.8%) a major  and  six 
(7.2%) a minor  amputat ion .  
Discuss ion  
A number  of  fac tors  have  been descr ibed  wh ich  in-  
f luence  long- term resu l ts  of  PTA.  These  inc lude  s tate  
of  run  off, 7'8 type  and  number  of  les ions  d i la ted ,  in-  
d icat ion  for  the  procedure ,  age  of the  pat ient ,  9whether  
or  not  the  les ion(s )  is above  the  ingu ina l  l igament ,  and  
presence  or  absence  of  d iabetes .  
Pat ients  w i th  s tenoses  ra ther  than  occ lus ions  have  
h is tor i ca l ly  been  most  amenab le  to PTA.  These  pat ients  
Eur J Vasc Endovasc Surg Vol 14, August 1997 
138 W. Gutteridge et al. 
Table 6. Life table: cumulative incidence of major amputation (on same side) following below inguinal igament angioplasty. 
Time interval No. of Major No. lost to No. of Risk of Chance of Cumulative Standard 
after angioplasty angioplasties amputations follow-up angioplasties having surviving chance of error 
(days) entering tim during during at risk during amputation interval surviving 
interval interval interval interval without without 
having a having an 
amputation amputation 
0-90 179 6 30 164 
91-180 143 3 15 135.5 
181-270 125 1 20 115 
271-360 105 1 21 94.5 
361-450 84 1 18 75 
451-540 66 -- 10 61 
541-630 56 -- 15 48.5 
631-720 41 -- 10 36 
721-810 31 -- 14 24 
811-900 17 -- 12 11 
0.0366 0.963 0.963 0.0144 
0.0221 0.978 0.942 0.0185 
0.0087 0.991 0.933 0.0201 
0.0106 0.989 0.923 0.0221 
0.0133 0.987 0.911 0.0250 
often have less severe symptoms. Johnston et al. found 
that only 13% of 984 patients having PTA had rest 
pain, ulceration or gangrene. I° The majority of patients 
had intermittent claudication. In our series, 27% of 
patients had critical ischaemia. However, as techniques 
improve and as more angioplasties of long occlusions 
are attempted, then there will be an increase in the 
number of patients with critical ischaemia so treated. 
In a recent report of 222 referrals with critical limb 
ischaemia, 42% had PTA as their first line of treatment. 3 
Of 108 attempted PTAs all but 16 were below the 
inguinal ligament. Limb salvage was achieved in al- 
most 90% of limbs. It is unlikely that these numbers 
will be reproduced nationally; however, there is little 
doubt that increasing numbers of PTAs are being 
carried out for critical leg ischaemia. H 
Although it is well established that patients with 
stenotic disease do better following angioplasty than 
those with occlusions, it is interesting to note that the 
indication for the procedure also has an effect. A 
recent study showed greater patency following PTA 
of stenoses for claudication compared with that of 
stenoses for critical ischaemia. 12In the present series 
there was little difference in the results when com- 
paring stenosis with occlusive disease. However, the 
length of occlusion treated was relatively short (me- 
dian length 5 cm). 
Patients originally presenting with rest pain, ul- 
ceration or gangrene were significantly more likely to 
require an amputation. No patient who originally 
presented with claudication lost their leg in the follow- 
up period. Death was also significantly more likely in 
those patients originally presenting with critical limb 
ischaemia. 
Following successful PTA of iliac lesions, 80-90% 5- 
year patency rates have been reported. I3"14 Patency of 
more distal lesions is not so good. Femoropopliteal 
lesions have patency rates of only 60-70% at 5 years. 
Complications occur in up to 12% of cases. 15-17 Less 
than 2% of patients will require emergency operation 
to deal with such complications. 9 They are more likely 
with lesions below compared with those above the 
inguinal igament. TM There is some evidence to suggest 
that patients with claudication who have disease below 
the inguinal ligament fare better with regard to clau- 
dication and maximum walking distance with a pro- 
gramme of exercise rather than PTA. I9 Others have 
suggested that because of the relatively high rate of 
complications and relatively poor patency, PTA should 
not be recommended for treating lesions below the 
inguinal igament in patients with claudication, s How- 
ever, quality of life can be improved when PTA is 
carried out for claudication. Several reports have 
shown improvement in quality of life which correlate 
with patency of the angioplastied segment. 2°'21 In this 
series no patient whose initial presentation was clau- 
dication required either a minor or major amputation 
during the period of follow-up. 
Several reports have emphasised the adverse in- 
fluence of diabetes on long-term patency following 
PTA. 1°'22'23 In this series no difference merged in the 
rate of reconstruction comparing diabetic with non- 
diabetic patients. However, minor and major am- 
putations were significantly more common in dia- 
betics. Furthermore, diabetics were significantly more 
likely to have disease below the inguinal ligament. 
More diabetic patients died during the follow-up 
period, but this failed to reach statistical significance. 
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